S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Cintas: A Quality Buy and Hold Forever Stock at Any Price
Laser breakthrough could send stock soaring 2,467% (Ad)
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
3 Household Names With RSIs That Scream Oversold
Laser breakthrough could send stock soaring 2,467% (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
This Little Known Automaker May Save Your Life and Your Portfolio
Laser breakthrough could send stock soaring 2,467% (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Cintas: A Quality Buy and Hold Forever Stock at Any Price
Laser breakthrough could send stock soaring 2,467% (Ad)
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
3 Household Names With RSIs That Scream Oversold
Laser breakthrough could send stock soaring 2,467% (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
This Little Known Automaker May Save Your Life and Your Portfolio
Laser breakthrough could send stock soaring 2,467% (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Cintas: A Quality Buy and Hold Forever Stock at Any Price
Laser breakthrough could send stock soaring 2,467% (Ad)
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
3 Household Names With RSIs That Scream Oversold
Laser breakthrough could send stock soaring 2,467% (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
This Little Known Automaker May Save Your Life and Your Portfolio
Laser breakthrough could send stock soaring 2,467% (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Cintas: A Quality Buy and Hold Forever Stock at Any Price
Laser breakthrough could send stock soaring 2,467% (Ad)
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
3 Household Names With RSIs That Scream Oversold
Laser breakthrough could send stock soaring 2,467% (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
This Little Known Automaker May Save Your Life and Your Portfolio
Laser breakthrough could send stock soaring 2,467% (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
OTCMKTS:VIMGF

Vimian Group AB (publ) (VIMGF) Stock Forecast, Price & News

C$2.25
0.00 (0.00%)
(As of 09/27/2023 ET)
Compare
Today's Range
C$2.25
C$2.25
50-Day Range
C$2.25
C$3.32
52-Week Range
C$2.25
C$2.25
Volume
N/A
Average Volume
360 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

VIMGF stock logo

About Vimian Group AB (publ) (OTCMKTS:VIMGF) Stock

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.

VIMGF Price History

VIMGF Stock News Headlines

Karnov Group AB (KARNO)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
See More Headlines
Receive VIMGF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vimian Group AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:VIMGF
CIK
N/A
Fax
N/A
Employees
1,068
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Fredrik Ullman (Age 43)
    Interim Chief Exec. Officer
    Comp: $403.4k
  • Mr. Carl-Johan Zetterberg Boudrie (Age 45)
    Chief Financial Officer
  • Ms. Maria Dahllof Tullberg (Age 42)
    Head of IR, Communications & Sustainability
  • Mr. Carl-Johan Ehn (Age 49)
    Gen. Counsel
  • Mr. Magnus Kjellberg (Age 50)
    Chief Exec. Officer of Nextmune
  • Mr. Martin Bengtson
    Head of M&A
  • Mr. Stefano Santarelli (Age 42)
    Chief Exec. Officer of Indical Bioscience
  • Mr. Guy C. Sporri (Age 43)
    Co-Chief Exec. Officer of Movora
  • Mr. Alireza Tajbakhsh (Age 40)
    Head & CEO of VetFamily
  • Colleen Flesher (Age 47)
    Co-Chief Exec. Officer of Movora













VIMGF Stock - Frequently Asked Questions

Should I buy or sell Vimian Group AB (publ) stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Vimian Group AB (publ) in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" VIMGF shares.
View VIMGF analyst ratings
or view top-rated stocks.

How have VIMGF shares performed in 2023?

Vimian Group AB (publ)'s stock was trading at C$3.20 at the start of the year. Since then, VIMGF shares have decreased by 29.7% and is now trading at C$2.25.
View the best growth stocks for 2023 here
.

What is Vimian Group AB (publ)'s stock symbol?

Vimian Group AB (publ) trades on the OTCMKTS under the ticker symbol "VIMGF."

How do I buy shares of Vimian Group AB (publ)?

Shares of VIMGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vimian Group AB (publ)'s stock price today?

One share of VIMGF stock can currently be purchased for approximately C$2.25.

How many employees does Vimian Group AB (publ) have?

The company employs 1,068 workers across the globe.

How can I contact Vimian Group AB (publ)?

Vimian Group AB (publ)'s mailing address is Riddargatan 19, Stockholm 11457, Sweden, . The official website for the company is vimian.com. The company can be reached via phone at 46 7 36 26 88 86.

This page (OTCMKTS:VIMGF) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -